Immunogenomics and Inflammation Research Unit EA4130, University of Lyon, Lyon, France.
Immunogenomics and Inflammation Research Unit EA4130, University of Lyon, Lyon, France.
Autoimmun Rev. 2018 Dec;17(12):1176-1185. doi: 10.1016/j.autrev.2018.06.008. Epub 2018 Oct 12.
The pro-inflammatory cytokine interleukin(IL)-17 and IL-17-producing cells are important players in the pathogenesis of many autoimmune / inflammatory diseases. More recently, they have been associated with liver diseases. This review first describes the general knowledge on IL-17 and IL-17 producing cells. The second part describes the in vitro and in vivo effects of IL-17 on liver cells and the contribution of IL-17 producing cells to liver diseases. IL-17 induces immune cell infiltration and liver damage driving to hepatic inflammation and fibrosis and contributes to autoimmune liver diseases. The circulating levels of IL-17 and the frequency of IL-17-producing cells are elevated in a variety of acute and chronic liver diseases. The last part focuses on the effects of IL-17 deletion or neutralization in various murine models. Some of these observed beneficial effects suggest that targeting the IL-17 axis could be a new therapeutic strategy to prevent chronicity and progression of various liver diseases.
促炎细胞因子白细胞介素(IL)-17 和产生 IL-17 的细胞是许多自身免疫/炎症性疾病发病机制中的重要参与者。最近,它们与肝脏疾病有关。这篇综述首先描述了关于 IL-17 和产生 IL-17 的细胞的一般知识。第二部分描述了 IL-17 在体外和体内对肝细胞的作用以及产生 IL-17 的细胞对肝脏疾病的贡献。IL-17 诱导免疫细胞浸润和肝脏损伤,导致肝炎症和纤维化,并有助于自身免疫性肝病。循环中 IL-17 的水平和产生 IL-17 的细胞的频率在各种急性和慢性肝脏疾病中升高。最后一部分重点介绍了在各种小鼠模型中 IL-17 缺失或中和的效果。这些观察到的一些有益效果表明,靶向 IL-17 轴可能是预防各种肝脏疾病慢性化和进展的新治疗策略。